Jennifer Parish, MD
Dermatology · Philadelphia, PANPI 1164412144
Payments from drug & device makers
Across 338 payments — averaging $2739.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$376K
- Pfizer$241K
- Janssen Research & Development, LLC$83K
- Incyte Corporation$63K
- Amgen$61K
- E.r. Squibb & Sons, L.L.C.$42K
- plus $60K from 11 others
Across 14 payments — averaging $12,146 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glenmark Pharmaceuticals Inc., USA$122K
- Ichnos Glenmark Innovation Inc$45K
- Amgen$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 24 | $375,743 |
| Pfizer | 79 | $240,951 |
| Janssen Research & Development, LLC | 16 | $83,080 |
| Incyte Corporation | 96 | $63,237 |
| Amgen(2 entities) | 18 | $60,940 |
| E.r. Squibb & Sons, L.L.C. | 7 | $42,286 |
| Galderma Laboratories, L.p. | 9 | $20,028 |
| Almirall LLC | 4 | $12,561 |
| Kiniksa Pharmaceuticals, Ltd. | 40 | $11,863 |
| Bristol Myers Squibb | 3 | $8,925 |
| Galderma Research & Development, LLC | 1 | $5,829 |
| AbbVie | 35 | $319 |
| Johnson & Johnson | 2 | $172 |
| Sun Pharmaceutical Industries Inc. | 1 | $72 |
| Novartis | 1 | $22 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
| Organon | 1 | $5 |
How this compares
$926,047 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Philadelphia
- Victoria WerthPhiladelphia$7.2M
- Joel GelfandPhiladelphia$3.6M
- Lawrence ParishPhiladelphia$2.9M
- Stephen HessPhiladelphia$1.7M
- Susan TaylorPhiladelphia$939K
- Nicholas MollanazarPhiladelphia$509K
- Zelma Chiesa FuxenchPhiladelphia$396K
- Katrina AbuabaraPhiladelphia$359K
- Joy WanPhiladelphia$358K
- Harold FarberPhiladelphia$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.